CLINICAL_TRIALS
trial_result
· 2013-02-11
Clinical Trial Update: Safety and Efficacy of Rasagiline in Restless Legs Syndrome [Phase 2, Phase 3]
Summary
A terminated Phase 2/Phase 3 trial evaluated the safety and efficacy of rasagiline in patients with restless legs syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Virginia | Conditions: Restless Legs Syndrome | Phase 2, Phase 3 | Status: TERMINATED